Maximum Strength Acid Reducer

Product NDC
49483-720
11-digit product format
494830720
Labeler code
49483
Product ID
49483-720_12f9b308-9375-2df3-e063-6394a90a8d22
Type
HUMAN OTC DRUG
Nonproprietary name
Famotidine
Dosage form
TABLET
Route
ORAL
Labeler
TIME CAP LABORATORIES,INC
Application
ANDA217543
Marketing category
ANDA
Marketing start
2023-06-15
Substance
FAMOTIDINE
Active strength
20 mg/1
Pharmacologic classes
Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A217543-001FAMOTIDINEFAMOTIDINE10MGTABLET / ORAL2023-03-08
A217543-002FAMOTIDINEFAMOTIDINE20MGTABLET / ORAL2023-03-08

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 50 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A217543-001FAMOTIDINE10MGTABLET / ORAL2023-03-0884e616aacf4f…
2026-09-14 22:38:342026-08A217543-002FAMOTIDINE20MGTABLET / ORAL2023-03-0884e616aacf4f…
2026-08-18 06:07:402026-07A217543-001FAMOTIDINE10MGTABLET / ORAL2023-03-08caaa826d4ba7…
2026-08-18 06:07:402026-07A217543-002FAMOTIDINE20MGTABLET / ORAL2023-03-08caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A217543-001FAMOTIDINE10MGTABLET / ORAL2023-03-08011fe1cb6892…
2026-02-19 14:30 UTC2026-02A217543-002FAMOTIDINE20MGTABLET / ORAL2023-03-08011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A217543-001FAMOTIDINE10MGTABLET / ORAL2023-03-0831067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A217543-002FAMOTIDINE20MGTABLET / ORAL2023-03-0831067a03dcf5…
2025-08-23 18:47 UTC2025-08A217543-001FAMOTIDINE10MGTABLET / ORAL2023-03-086a471c1ec25d…
2025-08-23 18:47 UTC2025-08A217543-002FAMOTIDINE20MGTABLET / ORAL2023-03-086a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A217543-001FAMOTIDINE10MGTABLET / ORAL2023-03-08fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A217543-002FAMOTIDINE20MGTABLET / ORAL2023-03-08fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A217543-001FAMOTIDINE10MGTABLET / ORAL2023-03-08b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A217543-002FAMOTIDINE20MGTABLET / ORAL2023-03-08b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A217543-001FAMOTIDINE10MGTABLET / ORAL2023-03-0803ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A217543-002FAMOTIDINE20MGTABLET / ORAL2023-03-0803ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A217543-001FAMOTIDINE10MGTABLET / ORAL2023-03-082680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A217543-002FAMOTIDINE20MGTABLET / ORAL2023-03-082680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A217543-001FAMOTIDINE10MGTABLET / ORAL2023-03-085bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A217543-002FAMOTIDINE20MGTABLET / ORAL2023-03-085bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A217543-001FAMOTIDINE10MGTABLET / ORAL2023-03-08d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A217543-002FAMOTIDINE20MGTABLET / ORAL2023-03-08d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A217543-001FAMOTIDINE10MGTABLET / ORAL2023-03-08d06236e962d9…
2024-10-29 15:01 UTC2024-10A217543-002FAMOTIDINE20MGTABLET / ORAL2023-03-08d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A217543-001FAMOTIDINE10MGTABLET / ORAL2023-03-0879d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A217543-002FAMOTIDINE20MGTABLET / ORAL2023-03-0879d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A217543-001FAMOTIDINE10MGTABLET / ORAL2023-03-08301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A217543-002FAMOTIDINE20MGTABLET / ORAL2023-03-08301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A217543-001FAMOTIDINE10MGTABLET / ORAL2023-03-081e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A217543-002FAMOTIDINE20MGTABLET / ORAL2023-03-081e350fbaab3a…
2024-05-31 18:47 UTC2024-05A217543-001FAMOTIDINE10MGTABLET / ORAL2023-03-088072bd15b7f6…
2024-05-31 18:47 UTC2024-05A217543-002FAMOTIDINE20MGTABLET / ORAL2023-03-088072bd15b7f6…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A217543-001FAMOTIDINE10MGTABLET / ORAL2023-03-086a51e52b5d6a…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A217543-002FAMOTIDINE20MGTABLET / ORAL2023-03-086a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A217543-001FAMOTIDINE10MGTABLET / ORAL2023-03-081c564ffb4f44…
2024-02-18 07:12 UTC2024-02A217543-002FAMOTIDINE20MGTABLET / ORAL2023-03-081c564ffb4f44…
2023-12-20 04:57 UTC2023-12A217543-001FAMOTIDINE10MGTABLET / ORAL2023-03-08ea1830bbd6c7…
2023-12-20 04:57 UTC2023-12A217543-002FAMOTIDINE20MGTABLET / ORAL2023-03-08ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A217543-001FAMOTIDINE10MGTABLET / ORAL2023-03-08a72a2bbeb626…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A217543-002FAMOTIDINE20MGTABLET / ORAL2023-03-08a72a2bbeb626…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
Maximum Strength Acid Reducer
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
FAMOTIDINE20 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
5QZO15J2Z8Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
310273Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
fe25e1e2-7158-6fe0-e053-6394a90a3bb1Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
396bde5c-c78e-2f8b-ab1f-2ee6ba32bcaeProduct name720260317
1e73f975-1ce7-705e-2bcf-788b1b5e24baProduct name520251124
cf645750-2e70-f6e1-c05a-a52847def5ddProduct name920250312
4fdc761c-585e-054b-8ebe-86130a26e4c1Product name220221205
fc2e1e31-353a-2c24-a4b4-fcf93bf7e38eProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
49483-720-01Maximum Strength Acid Reducer100 in 1 BOTTLETABLET1004
49483-720-20Maximum Strength Acid Reducer200 in 1 BOTTLETABLET2004

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
49483-720-01EA - Each49483-720d15f5ad1-6745-4159-96a2-abe5eee3473212024-03-12

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
49483-720MAXIMUM STRENGTH ACID REDUCER (FAMOTIDINE) TABLET [TIME CAP LABORATORIES,INC]4Current NDC, 2 package rows20240307_fe25e1e2-7158-6fe0-e053-6394a90a3bb1.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 6 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Famotidine 20 mgFAMOTIDINE 20 MGMARKSANS PHARMA LIMITED5a66206b-35b1-4d86-8574-a1e45cb0772f2025-05-06WarningsExact identifier
application applno (ANDA): 217543
application number: ANDA217543
Famotidine 10 mgFAMOTIDINE 10 MGMARKSANS PHARMA LIMITED58b653eb-6539-4b79-9d22-df6eaf35307f2024-09-30WarningsExact identifier
application applno (ANDA): 217543
application number: ANDA217543
Original strength heartburn preventionFAMOTIDINEKROGER COMPANYea1c2838-acbd-18e0-e053-2a95a90a35222024-07-08WarningsExact identifier
application applno (ANDA): 217543
application number: ANDA217543
Maximum Strength Acid ReducerFAMOTIDINETARGET CORPORATION07a924f1-14cc-4e7d-e063-6394a90ac7f32024-05-13WarningsExact identifier
application applno (ANDA): 217543
application number: ANDA217543
Maximum Strength Acid ReducerFAMOTIDINETIME CAP LABORATORIES,INCfe25e1e2-7158-6fe0-e053-6394a90a3bb12024-03-06WarningsExact identifier
application applno (ANDA): 217543
application number: ANDA217543
ndc (product): 49483-720
Maximum Strength Acid ControllerFAMOTIDINEBETTER LIVING BRANDS LLC.f2c031b4-de86-3a8e-e053-2a95a90a21e02023-07-30WarningsExact identifier
application applno (ANDA): 217543
application number: ANDA217543

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
310273famotidine 20 MG Oral TabletPSNfe25e1e2-7158-6fe0-e053-6394a90a3bb14
310273famotidine 20 MG Oral TabletSCDfe25e1e2-7158-6fe0-e053-6394a90a3bb14

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
49483-720-0149483072001100 TABLET in 1 BOTTLE (49483-720-01) 100 tablet2024-03-11NoNoCurrent
49483-720-2049483072020200 TABLET in 1 BOTTLE (49483-720-20) 200 tablet2023-06-15NoNoCurrent